{
    "nct_id": "NCT05784441",
    "official_title": "A Phase 1b Multicenter, Open-Label, Study of JNJ-90009530, an Autologous Anti-CD20 CAR-T Cell Therapy in Adult Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma",
    "inclusion_criteria": "Key Inclusion Criteria\n\n* Participant must be greater than or equal to (>=) 18 years of age, at the time of signing informed consent\n* All participants must have relapsed or refractory disease for each histologic subtype\n\n  * Mature aggressive large B cell NHL and Follicular Lymphoma Grade 3b: Participants must have >= 2 lines of systemic therapy or >=1 line of systemic therapy in case of participants ineligible for high-dose chemotherapy and autologous Hematopoietic stem cell transplantation (HSCT). Participants also must have had exposure to an anthracycline and an anti-CD20 targeted agent\n  * Follicular lymphoma Grade 1-3a and Marginal Zone Lymphoma: Participants must have >=2 prior lines of anti-neoplastic systemic therapy. Participants also must have prior exposure to an anti-CD20 monoclonal antibody\n* Tumor must be cluster of differentiation (CD) 20 positive\n* Measurable disease as defined by Lugano 2014 classification\n* Eastern Cooperative Oncology Group (ECOG) performance status of either 0 or 1\n\nKey Exclusion Criteria\n\n* Diagnosis of Human herpes virus (HHV) 8-positive Diffuse large B Cell lymphoma (DLBCL)\n* Prior allogeneic Hematopoietic stem cell transplantation (HSCT)\n* Autologous stem cell transplant within 12 weeks of chimeric antigen receptor (CAR) T cell infusion\n* Uncontrolled active infections\n* History of deep vein thrombosis or pulmonary embolism within six months of infusion (except for line associated deep vein thrombosis [DVT])\n* History of stroke, unstable angina, myocardial infarction, congestive heart failure ( New York Heart Association [NYHA] Class III or IV), severe cardiomyopathy or ventricular arrhythmia requiring medication or mechanical control within 6 months of screening\n* History of a seizure disorder, dementia, cerebellar disease or neurodegenerative disorder\n* Known history or prior diagnosis of optic neuritis or other immunologic or inflammatory disease affecting the central nervous system\n* Active central nervous system (CNS) involvement by malignancy\n* Current active liver or biliary disease (except for Gilbert's syndrome or asymptomatic gallstones)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}